HMGB2 inhibitors encompass a varied group of compounds that can affect HMGB2 functionality by diverse mechanisms. These range from direct competition for DNA binding sites to the suppression of HMGB2 synthesis. Minor groove binders such as Distamycin A, Mithramycin A, Netropsin, and Chromomycin A3 act by occupying the DNA regions where HMGB2 typically binds. By doing so, they can impede HMGB2's ability to interact with DNA, which is essential for its role in chromatin remodeling and transcriptional regulation. On the other hand, agents that affect gene expression, such as Hesperidin and Epigallocatechin gallate, can influence the cellular levels of HMGB2. These do not directly target HMGB2 but may lead to a decrease in its synthesis and availability within the cell.
More broadly acting compounds like Ricin and α-Amanitin are potent inhibitors of protein synthesis. Their effect on HMGB2 would be part of a general decrease in cellular protein levels, including those involved in chromatin organization and transcriptional regulation. Actinomycin D, a classic transcription inhibitor, can suppress HMGB2 transcription directly. Meanwhile, DNA intercalators such as Ellipticine, Daunorubicin, and Mitoxantrone can hinder HMGB2's access to DNA by changing the DNA structure, thus preventing HMGB2 from exerting its biological functions.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Mithramycin A | 18378-89-7 | sc-200909 | 1 mg | $55.00 | 6 | |
By binding to GC-rich sequences in the minor groove of DNA, this compound could prevent HMGB2 binding to these regions. | ||||||
Chromomycin A3 | 7059-24-7 | sc-200907 | 10 mg | $260.00 | ||
It binds to G-C rich sequences of DNA, which could block HMGB2 from accessing its usual binding sites on the DNA. | ||||||
Hesperidin | 520-26-3 | sc-205711 sc-205711A | 25 g 100 g | $82.00 $204.00 | 5 | |
Flavonoid that can influence gene expression; it may alter HMGB2 levels or modify its interaction with DNA or other chromosomal proteins. | ||||||
(−)-Epigallocatechin Gallate | 989-51-5 | sc-200802 sc-200802A sc-200802B sc-200802C sc-200802D sc-200802E | 10 mg 50 mg 100 mg 500 mg 1 g 10 g | $43.00 $73.00 $126.00 $243.00 $530.00 $1259.00 | 11 | |
A catechin found in green tea that may modulate protein expression, including potentially reducing HMGB2 expression. | ||||||
α-Amanitin | 23109-05-9 | sc-202440 sc-202440A | 1 mg 5 mg | $269.00 $1050.00 | 26 | |
An inhibitor of RNA polymerase II that can suppress transcription, potentially decreasing HMGB2 synthesis. | ||||||
Actinomycin D | 50-76-0 | sc-200906 sc-200906A sc-200906B sc-200906C sc-200906D | 5 mg 25 mg 100 mg 1 g 10 g | $74.00 $243.00 $731.00 $2572.00 $21848.00 | 53 | |
Interacts with DNA and inhibits RNA synthesis; could reduce HMGB2 levels by preventing its transcription. | ||||||
Ellipticine | 519-23-3 | sc-200878 sc-200878A | 10 mg 50 mg | $145.00 $569.00 | 4 | |
Alkaloid that intercalates into DNA and can disrupt the normal function of DNA-binding proteins like HMGB2. | ||||||
Daunorubicin hydrochloride | 23541-50-6 | sc-200921 sc-200921A sc-200921B sc-200921C | 10 mg 50 mg 250 mg 1 g | $105.00 $438.00 $837.00 $1569.00 | 4 | |
An anthracycline that intercalates into DNA and could block HMGB2 from binding to DNA, inhibiting its function. | ||||||
Mitoxantrone | 65271-80-9 | sc-207888 | 100 mg | $285.00 | 8 | |
A synthetic anthracenedione that intercalates into DNA, potentially hindering HMGB2 DNA-binding activity. | ||||||